Assyro AI

Assyro AI: Regulatory Copilot for Pharma & Biotech

导言

Assyro AI is your regulatory copilot for pharma and biotech. Accelerate drug submissions, reduce risk, and cut costly rework with AI.


社交和电子邮件:

更新日期:

2026年1月13日

每月访客数:

SimilarWeb Icon
815

联盟计划:

No

Assyro AI's 概述

Regulatory Copilot for Pharma & Biotech is an AI-driven tool designed to streamline drug submissions, significantly reducing the time and cost associated with regulatory processes. With features like clause-level intelligence, real-time eCTD validation, and audit-ready trails, it enables users to draft documents three times faster and validate them in half the time, ensuring submissions are free from rework. This innovative solution is tailored for the pharmaceutical and biotech industries, aiming to enhance efficiency and compliance in regulatory submissions.


Assyro AI's 特点

  • Clause-level intelligence

  • Real-time eCTD validation

  • Audit-ready trails

  • Faster document drafting

  • Reduced submission errors

  • Cost-effective regulatory processes

  • Streamlined compliance


Assyro AI's 问答


Assyro AI's 优点和缺点

优点

  • Accelerates drug submission processes
  • Reduces risk of errors
  • Saves time and costs
  • User-friendly interface
  • Supports compliance with regulations

缺点

  • Currently in early access phase
  • Limited information on long-term pricing
  • May require training for new users

Assyro AI's 使用案例

  • Accelerating drug submissions
  • Enhancing regulatory compliance
  • Reducing costs in drug development
  • Improving efficiency in biotech processes

Assyro AI's 目标受众

  • Pharmaceutical companies
  • Biotech firms
  • Regulatory affairs professionals
  • Compliance officers

Assyro AI's 定价

Early access is available for free.

Assyro AI's 分析

网站概述

关键性能指标 assyro.com

跳出率

40.64%

页面/访问

1.62

总访问量

815

现场时间

0m 27s

全球排名

#0

国家排名

#0

顶级地区

按国家分列的交通流量分布情况

  • 1.
    United States100.00%

游客总数

过去 3 个月的每月访客统计

发展趋势 by 347.8% 本月
October - December 2026

流量来源

流量来源分布

Social:
10.0%
Paid Referrals:
1.7%
Mail:
0.2%
Referrals:
12.7%
Search:
32.6%
Direct:
41.8%
主要来源: Direct
41.8% 占总流量的百分比

Assyro AI's 替代品